全球製藥 4.0 市場按組件、技術、應用、最終用戶和地區分類

Global Pharma 4.0 Market, By Component, By Technology, By Application, By End User, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 178 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球製藥 4.0 市場規模為 168.1 億美元，到 2032 年將達到 551.6 億美元，2025 年至 2032 年的複合年成長率為 18.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	168.1億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	18.50%	2032年價值預測	551.6億美元

數字。 2025年全球市場佔有率（%）

Pharma 4.0是指製藥業依照工業4.0原則進行的轉型。工業 4.0 的特點是將物聯網 (IoT)、人工智慧 (AI)、巨量資料分析、雲端運算和網實整合系統等先進技術融入製造流程。在製藥業，這意味著藥物開發、製造、供應鏈管理和整體業務效率的提高。 Pharma 4.0 是指製藥業的第四次工業革命，其特點是物聯網 (IoT)、巨量資料分析、人工智慧 (AI) 和機器學習等先進技術的融合。這些技術正在徹底改變製藥價值鏈的各個方面，從研發、臨床試驗到製造。我們也透過幫助製藥公司開發創新的標靶治療和精準藥物來實現個人化醫療。由於領導企業擴大採用這些新興技術來降低成本、提高生產力並獲得競爭優勢，預計全球 Pharma 4.0 市場將在未來幾年大幅成長。

市場動態：

全球製藥 4.0 市場受到多種因素的推動，例如對改善藥物發現和上市流程的需求日益成長、對個人化藥物的需求日益增加、對製造業務數位化的關注日益增加，以及製藥公司提高其供應鏈可見度和效率的目標。然而，引入新技術所需的高投資成本以及安全漏洞和網路攻擊的風險對市場成長構成了障礙。 Pharma 4.0 透過數據驅動的研究和開發、臨床試驗和供應鏈機會的預測分析、新數位療法的開發以及採用 3D 列印進行定製藥物製造，提供了重大機會。主要企業正專注於新產品的推出和夥伴關係關係，以利用這些機會。

本研究的主要特點

本報告對全球製藥 4.0 市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率(CAGR)。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球 Pharma 4.0 市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球製藥 4.0 市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
透過用於分析全球製藥 4.0 市場的各種策略矩陣，相關人員可以更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 16.81 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	18.50%	2032 Value Projection:	USD 55.16 Bn

The term Pharma 4.0 refers to the transformation in the pharmaceutical industry that is aligned with the principles of Industry 4.0. Industry 4.0 is characterized by the integration of advanced technologies such as the Internet of Things (IoT), artificial intelligence (AI), big data analytics, cloud computing, and cyber-physical systems into manufacturing processes. In the context of the pharmaceutical industry, this translates to improvements in drug development, manufacturing, supply chain management, and overall operational efficiency. Pharma 4.0 refers to the fourth industrial revolution in the pharmaceutical industry, characterized by the integration of advanced technologies like the Internet of Things (IoT), big data analytics, artificial intelligence (AI), and machine learning. These technologies are revolutionizing various aspects of the pharmaceutical value chain from research and development, clinical trials, production. They are also enabling personalized healthcare by helping pharma companies develop innovative targeted therapies and precision medicine. The global pharma 4.0 market is projected to grow significantly in the coming years as major players are increasingly adopting these emerging technologies to minimize costs, enhance productivity, and gain a competitive edge.

Market Dynamics:

The global pharma 4.0 market is driven by several factors, such as the growing need to improve drug discovery and development processes, rising demand for personalized medicines, an increasing focus on digitalizing manufacturing operations, and the aims of pharmaceutical companies to enhance supply chain visibility and efficiency. However, the high investment costs required for the implementation of emerging technologies, the risks of security breaches, and cyberattacks pose challenges to market growth. Pharma 4.0 offers huge opportunities by enabling data-driven research and development, predictive analytics for clinical trials and supply chain disruptions, the development of new digital therapies, and the adoption of 3D printing for customized drug manufacturing. Key players are focusing on new product launches and partnerships to capitalize on these opportunities.

Key features of the study:

This report provides in-depth analysis of the global pharma 4.0 market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharma 4.0 market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Oracle,GE Healthcare, Optum, Inc., Honeywell International Inc., IBM Corporation, Cisco Systems, Inc., Siemens Healthcare GmbH, POLARISqb, Google Cloud, Optibrium, Syntekabio, Fujitsu Limited, SAS Health, Microsoft and Lotte Healthcare
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global pharma 4.0 market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharma 4.0 market

Detailed Segmentation:

Global Pharma 4.0 Market, By Component
- Hardware
- Software
- Services
Global Pharma 4.0 Market, By Technology
- Cloud Computing
- Artificial Intelligence
- Big Data Analytics
- Internet of Things
Global Pharma 4.0 Market, By Application
- Research and Development
- Manufacturing
- Supply Chain Management
- Others
Global Pharma 4.0 Market, By End User
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
- Contract Research Organizations
Global Pharma 4.0 Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Oracle
- GE Healthcare
- Optum, Inc.
- Honeywell International Inc.
- IBM Corporation
- Cisco Systems, Inc.
- Siemens Healthcare GmbH
- POLARISqb
- Google Cloud
- Optibrium
- Syntekabio
- Fujitsu Limited
- SAS Health
- Microsoft
- Lotte Healthcare

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Component
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing Product Launch
- Data Security and Privacy Concerns
- Advancements in Artificial Intelligence and Analytics
Key Highlights
Regulatory Scenario
Market Trends
PEST Analysis
PORTER's Analysis
Product Launches
Technological Advancements
Mergers, Acquisitions, and Collaborations

4. Global Pharma 4.0 Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pharma 4.0 Market, By Component, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Pharma 4.0 Market, By Technology, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cloud Computing,
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Artificial Intelligence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Big Data Analytics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Internet of Things
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Pharma 4.0 Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Supply Chain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Pharma 4.0 Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Manufacturing Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Pharma 4.0 Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profile
- Oracle
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- GE Healthcare
- Optum, Inc.
- Honeywell International Inc.
- IBM Corporation
- Cisco Systems, Inc
- Siemens Healthcare GmbH
- POLARISqb
- Google Cloud
- Optibrium
- Syntekabio
- Fujitsu Limited
- SAS Health
- Microsoft
- Lotte Healthcare
Analyst Views